L Barrera

1.3k total citations
20 papers, 827 citations indexed

About

L Barrera is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, L Barrera has authored 20 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in L Barrera's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (11 papers) and Salivary Gland Disorders and Functions (2 papers). L Barrera is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (11 papers) and Salivary Gland Disorders and Functions (2 papers). L Barrera collaborates with scholars based in Argentina, United States and Spain. L Barrera's co-authors include Viviana Ritacco, Beatriz López, Kristin Kremer, Kris Huygen, Rogélio Hernández‐Pando, Clara Espitia, D Aguilar, Marion Burger, Héctor Orozco and Dick van Soolingen and has published in prestigious journals such as Journal of Clinical Microbiology, Clinical & Experimental Immunology and The Pediatric Infectious Disease Journal.

In The Last Decade

L Barrera

19 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Barrera Argentina 9 769 687 324 111 104 20 827
D Aguilar Mexico 7 953 1.2× 777 1.1× 406 1.3× 275 2.5× 178 1.7× 8 1.1k
Beatriz López Argentina 19 1.2k 1.6× 1.1k 1.6× 515 1.6× 249 2.2× 192 1.8× 49 1.4k
Masanori Kai Japan 14 402 0.5× 351 0.5× 216 0.7× 98 0.9× 154 1.5× 31 632
S K Furney United States 12 613 0.8× 520 0.8× 116 0.4× 272 2.5× 185 1.8× 13 791
Marion Burger Brazil 8 625 0.8× 541 0.8× 278 0.9× 100 0.9× 87 0.8× 14 702
Masanori Matsuoka Japan 20 952 1.2× 812 1.2× 459 1.4× 67 0.6× 107 1.0× 65 1.1k
Anzaan Dippenaar South Africa 17 720 0.9× 638 0.9× 220 0.7× 55 0.5× 233 2.2× 53 855
Barry J. Wards New Zealand 11 484 0.6× 417 0.6× 63 0.2× 185 1.7× 153 1.5× 17 581
Nicoletta Lari Italy 15 642 0.8× 690 1.0× 270 0.8× 33 0.3× 127 1.2× 36 773
Tanja Kubica Germany 15 1.0k 1.3× 963 1.4× 544 1.7× 26 0.2× 165 1.6× 18 1.1k

Countries citing papers authored by L Barrera

Since Specialization
Citations

This map shows the geographic impact of L Barrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Barrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Barrera more than expected).

Fields of papers citing papers by L Barrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Barrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Barrera. The network helps show where L Barrera may publish in the future.

Co-authorship network of co-authors of L Barrera

This figure shows the co-authorship network connecting the top 25 collaborators of L Barrera. A scholar is included among the top collaborators of L Barrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Barrera. L Barrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrera, L, et al.. (2025). Role of the anti-RO/SSA antibody in patients with systemic lupus erythematosus. Reumatología Clínica. 21(3). 501816–501816. 1 indexed citations
2.
Barrera, L, et al.. (2025). Role of the anti-RO/SSA antibody in patients with systemic lupus erythematosus. Reumatología Clínica (English Edition). 21(3). 501816–501816.
3.
Kurbatova, Ekaterina V., Joseph S. Cavanaugh, N. Sarita Shah, et al.. (2012). Rifampicin-resistant <I>Mycobacterium tuberculosis</I>: susceptibility to isoniazid and other anti-tuberculosis drugs [Short communication]. The International Journal of Tuberculosis and Lung Disease. 16(3). 355–357. 29 indexed citations
4.
Deun, Armand Van, L Barrera, I. Bastian, et al.. (2009). Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results. Journal of Clinical Microbiology. 47(11). 3501–3506. 156 indexed citations
5.
Martin, Anandi, Nora Morcillo, Dihadenys Lemus, et al.. (2004). La cultura, ¿universo compartido? : la didáctica intercultural en la enseñanza de idiomas. PubMed. 9(8). 12–6. 78 indexed citations
6.
López, Beatriz, D Aguilar, Héctor Orozco, et al.. (2003). A marked difference in pathogenesis and immune response induced by differentMycobacterium tuberculosisgenotypes. Clinical & Experimental Immunology. 133(1). 30–37. 366 indexed citations
7.
López, Beatriz, et al.. (2002). [The Mycobacteria Growth Indicator Tube (MGIT) is useful for anticipating the resistance of Mycobacterium tuberculosis to rifampicin but not to isoniazid].. PubMed. 33(4). 197–202. 1 indexed citations
8.
Reniero, Ana, et al.. (2002). [False-positive cultures due to cross contamination in tuberculosis laboratories].. PubMed. 34(3). 163–6. 1 indexed citations
9.
Barrera, L. (2000). La tuberculosis vista con el lente de aproximación de la biología molecular. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1 indexed citations
10.
Barrera, L, et al.. (2000). Diagnóstico de la tuberculosis infantil en provincias de la Argentina. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 3 indexed citations
11.
Kantor, Isabel N, L Barrera, & Viviana Ritacco. (1996). ¿Es la tuberculosis multirresistente una infección emergente en Buenos Aires?. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2 indexed citations
12.
Barrera, L, et al.. (1994). [Humoral response to mycobacteria in patients with Crohn disease].. PubMed. 54(2). 97–102. 2 indexed citations
13.
László, A, et al.. (1992). Evaluation of synthetic pseudo cord-factor-like glycolipids for the serodiagnosis of tuberculosis. Research in Microbiology. 143(2). 217–223. 10 indexed citations
14.
Barrera, L, Isabel de Kantor, Viviana Ritacco, et al.. (1992). Humoral response to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Tubercle and Lung Disease. 73(4). 187–191. 21 indexed citations
15.
Ritacco, Viviana, et al.. (1991). Reciprocal cellular and humoral immune responses in bovine tuberculosis. Research in Veterinary Science. 50(3). 365–367. 106 indexed citations
16.
Barrera, L, et al.. (1991). [Usefulness of the enzyme immunoassay in the diagnosis of tuberculosis].. PubMed. 110(6). 461–70. 2 indexed citations
17.
Barrera, L, et al.. (1989). Detection of circulating antibodies to purified protein derivative by enzyme-linked immunosorbent assay. The Pediatric Infectious Disease Journal. 8(11). 763–766. 24 indexed citations
18.
Barrera, L, Viviana Ritacco, Caroline Eisele, et al.. (1989). [Evaluation of an enzyme immunoassay for the rapid diagnosis of paucibacillary tuberculosis in adults].. PubMed. 49(6). 561–6. 4 indexed citations
19.
López, Beatriz, et al.. (1988). [Evaluation of four antigens for the detection of anti-Mycobacterium bovis antibodies by enzyme immunoassay].. PubMed. 20(2). 97–101. 1 indexed citations
20.
Barrera, L & Isabel N Kantor. (1987). Nontuberculous mycobacteria and Mycobacterium bovis as a cause of human disease in Argentina.. PubMed. 39(3). 222–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026